Abstract
Clinical manifestations of COVID-19 are different. There are some risk factors for COVID-19. This study aimed to describe the epidemiological features, symptoms and mortality of the patients with COVID-19 in Iran. This were a cohort study performed on 103,179 patients with COVID-19. The demographic and clinical data were collected in selected provinces. The required data of all patients was extracted from the COVID registry system and analyzed using STATA version 14 and Excel 2016. The mean age was 52.40 years for men and 52.41 years for women. About 55.2% of the study population were male and 44.8% were female. Totally, 60.9% (5085) of deaths happened in men and 39.1% (3263) in women. The mean time from onset of symptoms to hospitalization in men and women were 3.47 and 3.48 days, respectively. The mean time from onset of symptoms to isolation was 2.81 days in men and was 2.87 days in women, from onset of symptoms to death was 9.29 and 9.54 days, respectively, from onset of symptoms to discharge was 7.47 and 7.39 days, and from hospitalization to death was 6.76 and 7.05 days. Cough and shortness of breath were the most common symptoms in the patients. According to the results, the overall mortality rate was higher in men than women. Women with cardiovascular disease and diabetes were more likely to die. The mean time from onset of symptoms to hospitalization, isolation, and discharge was similar in men and women.
Highlights
Severe acute respiratory syndrome coronavirus 2 (SARS– CoV–2) is a newly recognized disease that has spread rapidly from Wuhan (Hubei province) to other provinces in China and around the world.[1,2] Since the outbreak of the new coronavirus pneumonia, with the rapid spread in the country and even the world, the number of infected cases has increased exponentially.[3,4]The rapid spread of COVID–19 has attracted worldwide attention, and the World Health Organization (WHO) has designated it as a public health emergency, international concern, and pandemic.[5,6] The spread of COVID–19 has been shown to occur in individuals through droplets, aerosols, feces, and oral mucosa.[7]
The present study was performed on 103 179 patients with COVID–19
The results showed that the mean time from onset of symptoms to hospitalization in men and women were 3.47 ± 2.11 and 3.48 ± 2.07 days, respectively
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS– CoV–2) is a newly recognized disease that has spread rapidly from Wuhan (Hubei province) to other provinces in China and around the world.[1,2] Since the outbreak of the new coronavirus pneumonia, with the rapid spread in the country and even the world, the number of infected cases has increased exponentially.[3,4]The rapid spread of COVID–19 has attracted worldwide attention, and the World Health Organization (WHO) has designated it as a public health emergency, international concern, and pandemic.[5,6] The spread of COVID–19 has been shown to occur in individuals through droplets, aerosols, feces, and oral mucosa.[7]. This study aimed to describe the epidemiological features, symptoms and mortality of the patients with COVID–19 in Iran. Methods: This were a cohort study performed on 103,179 patients with COVID–19. The mean time from onset of symptoms to hospitalization in men and women were 3.47 and 3.48 days, respectively. The mean time from onset of symptoms to isolation was 2.81 days in men and was 2.87 days in women, from onset of symptoms to death was 9.29 and 9.54 days, respectively, from onset of symptoms to discharge was 7.47 and 7.39 days, and from hospitalization to death was 6.76 and 7.05 days. The mean time from onset of symptoms to hospitalization, isolation, and discharge was similar in men and women.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
